Skip to main content

ProQR Therapeutics N.V.

PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612940

In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding ProQR Therapeutics N.V. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PRQR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders4655+9
Shares16.7M22.3M+5.64M (+33.8%)
Value$60.0M$47.5M−$12.4M (−20.7%)

New holders (17)

Institutions that held ProQR Therapeutics N.V. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to PRQR in Q1 2023
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC2,902,715$6.18M0.20%
DAFNA Capital Management LLC940,582$2.00M0.60%
UBS Oconnor LLC180,000$383.4K0.01%
HRT Financial LP171,306$364.0K0.00%
Citadel Advisors LLC99,779$212.5K0.00%
Virtu Financial LLC94,564$201.0K0.02%
Occudo Quantitative Strategies LP88,617$188.8K0.02%
Verition Fund Management LLC63,847$136.0K0.00%
Kapitalo Investimentos Ltda54,811$116.7K0.04%
Rafferty Asset Management, LLC21,680$46.2K0.00%
Two Sigma Securities, LLC19,041$40.6K0.00%
StoneX Group Inc.14,900$31.7K0.00%
Northern Trust Corp11,248$24.0K0.00%
XTX Topco Ltd10,160$21.6K0.00%
Vontobel Holding Ltd.10,000$21.3K0.00%
Lazard Asset Management LLC5,757$12.0K0.00%
Point72 Middle East FZE5,252$11.2K0.00%

Sold out (8)

Institutions that held ProQR Therapeutics N.V. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of PRQR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
AWM Investment Company, Inc.166,667$616.7K
Susquehanna International Group, LLP164,821$609.8K
Bank of Montreal102,551$381.5K
Gilder Gagnon Howe & Co LLC96,993$358.9K
Gsa Capital Partners LLP21,514$80.0K
Acadian Asset Management LLC17,256$63.0K
Belvedere Trading LLC11,357$42.0K
Citigroup Inc76$281